Search Within

Ross Levine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • JAK2 the future: Therapeutic strategies for JAK-dependent malignancies
    Journal Article

    LaFave, L. M.; Levine, R. L.
    Trends in Pharmacological Sciences (2012)

    Fulltext@MSK | Save
  • Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
    Journal Article

    Kämpjärvi, K.; Mäkinen, N.; Kilpivaara, O.; Arola, J.; Heinonen, H. R.; Böhm, J.; Abdel-Wahab, O.; Lehtonen, H. J.; Pelttari, L. M.; Mehine, M.; more...
    British Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
    Journal Article

    Busque, L.; Patel, J. P.; Figueroa, M. E.; Vasanthakumar, A.; Provost, S.; Hamilou, Z.; Mollica, L.; Li, J.; Viale, A.; Heguy, A.; more...
    Nature Genetics (2012)

    Fulltext@MSK | Save
  • Non-CML myeloproliferative diseases - Preface
    Journal Article

    Levine, R. L.
    Hematology/Oncology Clinics of North America (2012)

    Fulltext@MSK | Save
  • Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes
    Journal Article

    Bejar, R.; Stevenson, K. E.; Caughey, B. A.; Abdel-Wahab, O.; Steensma, D. P.; Galili, N.; Raza, A.; Kantarjian, H.; Levine, R. L.; Neuberg, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms
    Journal Article

    Abdel-Wahab, O.; Tefferi, A.; Levine, R. L.
    Hematology/Oncology Clinics of North America (2012)

    Fulltext@MSK | Save
  • IDH1 mutations disrupt blood, brain, and barriers
    Journal Article

    Shih, A. H.; Levine, R. L.
    Cancer Cell (2012)

    Fulltext@MSK | Save
  • The role of mutations in epigenetic regulators in myeloid malignancies
    Journal Article

    Shih, A. H.; Abdel-Wahab, O.; Patel, J. P.; Levine, R. L.
    Nature Reviews Cancer (2012)

    Fulltext@MSK | Save
  • Heterodimeric JAK STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Journal Article

    Koppikar, P.; Bhagwat, N.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Hricik, T.; Liu, F.; Saunders, L. M.; Mullally, A.; Abdel-Wahab, O.; more...
    Nature (2012)

    Fulltext@MSK | Save
  • CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
    Journal Article

    Gonen, M.; Sun, Z.; Figueroa, M. E.; Patel, J. P.; Abdel-Wahab, O.; Racevskis, J.; Ketterling, R. P.; Fernandez, H.; Rowe, J. M.; Tallman, M. S.; more...
    Blood (2012)

    Fulltext@MSK | Save